Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform
Go back to Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform| Xenetic Biosciences, Inc. (NASDAQ: XBIO) | Delayed: 4.67 +0.04 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $5.20 | |||
| Open | $4.73 | 52 Week Low | $0.21 | |||
| Day High | $4.90 | P/E | N/A | |||
| Day Low | $4.41 | EPS | $-0.01 | |||
| Volume | 79,166 | |||||
